Effects of acute tryptophan depletion in serotonin reuptake inhibitor-remitted patients with generalized anxiety disorder

Psychopharmacology

Volumn 208, Issue 2, 2010, Pages 223-232

  Hood, Sean D ^a,b   Hince, Dana A ^a,b   Davies, Simon J C ^b   Argyropoulos, Spilios ^b,c   Robinson, Hayley ^a   Potokar, John ^b   Nutt, David J ^b,d  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Psychopharmacology Unit   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d Division of Neuroscience and Mental Health   (United Kingdom)

Author keywords

Anxiety; GAD; Serotonin; SSRI; Tryptophan

Indexed keywords

AMINO ACID TRANSPORTER; ESCITALOPRAM; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRYPTOPHAN; VENLAFAXINE; AMINO ACID; ANXIOLYTIC AGENT; CARBON DIOXIDE;

ABDOMINAL DISCOMFORT; ADULT; ARTICLE; CARBON DIOXIDE BREATHING; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; GENERALIZED ANXIETY DISORDER; HEART RATE; HUMAN; MAJOR DEPRESSION; MALE; NAUSEA; PANIC; PRIORITY JOURNAL; PROFILE OF MOOD STATES; RANDOMIZED CONTROLLED TRIAL; SEROTONINERGIC TRANSMISSION; STATE TRAIT ANXIETY INVENTORY; SYSTOLIC BLOOD PRESSURE; VISUAL ANALOG SCALE; AFFECT; ANXIETY DISORDER; AUSTRALIA; BEVERAGE; BLOOD; BLOOD PRESSURE; DRUG EFFECT; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; TREATMENT OUTCOME; UNITED KINGDOM;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADULT; AFFECT; AMINO ACIDS; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; BEVERAGES; BLOOD PRESSURE; CARBON DIOXIDE; DOUBLE-BLIND METHOD; ENGLAND; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME; TRYPTOPHAN; WESTERN AUSTRALIA;

EID: 77449130264     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1722-1     Document Type: Article

References (45)

1. American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders. APA, Washington
2. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. APA, Washington
3. T Ardis M Cahir J Elliott R Bell G Reynolds S Cooper 2009 Effect of acute tryptophan depletion on noradrenaline and dopamine in the rat brain J Psychopharmacol 23 51 55 10.1177/0269881108089597 1:CAS:528:DC%2BD1MXisVClu7o%3D 18562433
4. SV Argyropoulos JE Bailey SD Hood AH Kendrick AS Rich G Laszlo JR Nash SL Lightman DJ Nutt 2002 Inhalation of 35% CO(2) results in activation of the HPA axis in healthy volunteers Psychoneuroendocrinology 27 715 729 10.1016/S0306-4530(01)00075-0 1:CAS:528:DC%2BD38XkslGqsLk%3D 12084664
5. SV Argyropoulos SD Hood M Adrover CJ Bell AS Rich JR Nash NC Rich HJ Witchel DJ Nutt 2004 Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder Biol Psychiatry 56 503 509 10.1016/j.biopsych.2004.07.006 1:CAS:528: DC%2BD2cXnvV2ms7w%3D 15450786
6. 2 in human volunteers Depress Anxiety 21 18 25 10.1002/da.20048 15782425
7. 2 model of GAD using paroxetine and lorazepam in healthy volunteers J Psychopharmacol 21 42 49 10.1177/0269881106063889 1:CAS:528:DC%2BD2sXhvFylsbc%3D 16533865
8. DS Baldwin IM Anderson DJ Nutt B Bandelow A Bond JR Davidson JA Den Boer NA Fineberg M Knapp J Scott HU Wittchen 2005 Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology J Psychopharmacol 19 567 596 10.1177/0269881105059253 1:CAS:528:DC%2BD2MXht1Kru77N 16272179
9. LC Barr WK Goodman CJ McDougle PL Delgado GR Heninger DS Charney LH Price 1994 Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors Arch Gen Psychiatry 51 309 317 1:STN:280:DyaK2c3htlGkuw%3D%3D 8161291
10. C Bell J Abrams D Nutt 2001 Tryptophan depletion and its implications for psychiatry Br J Psychiatry 178 399 405 10.1192/bjp.178.5.399 1:STN:280:DC%2BD3Mzps1ekug%3D%3D 11331552
11. C Bell S Forshall M Adrover J Nash S Hood S Argyropoulos A Rich DJ Nutt 2002 Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine J Psychopharmacol 16 5 14 10.1177/ 026988110201600116 1:CAS:528:DC%2BD38Xjt1yms7o%3D 11949771
12. CJ Bell SD Hood DJ Nutt 2005 Acute tryptophan depletion. Part II: clinical effects and implications Aust N Z J Psychiatry 39 565 574 15996137
13. A Berney D Sookman M Leyton SN Young C Benkelfat 2006 Lack of effects on core obsessive-compulsive symptoms of tryptophan depletion during symptom provocation in remitted obsessive-compulsive disorder patients Biol Psychiatry 59 853 857 10.1016/j.biopsych.2005.08.023 1:CAS:528:DC%2BD28XjsFOnt7k%3D 16213470
14. AJ Bond MH Lader 1974 The use of analogue scales in rating subjective feelings Br J Med Psychology 47 211 218
15. M Cahir TC Ardis JJ Elliott CB Kelly GP Reynolds SJ Cooper 2008 Acute tryptophan depletion does not alter central or plasma brain-derived neurotrophic factor in the rat Eur Neuropsychopharmacol 18 317 322 10.1016/j.euroneuro.2007. 07.006 1:CAS:528:DC%2BD1cXjtlWhsbk%3D 17719210
16. LL Carpenter GM Anderson GH Pelton JA Gudin PD Kirwin LH Price GR Heninger CJ McDougle 1998 Tryptophan depletion during continuous CSF sampling in healthy human subjects Neuropsychopharmacology 19 26 35 10.1016/S0893-133X(97) 00198-X 1:CAS:528:DyaK1cXjsVOru7c%3D 9608574
17. Corchs F, Nutt DJ, Hood S, Bernik M (2009) Serotonin and sensitivity to trauma-related exposure in selective serotonin reuptake inhibitors-recovered posttraumatic stress disorder. Biol Psychiatry 66:17-24
18. C Czermak R Hauger WC Drevets DA Luckenbaugh M Geraci DS Charney A Neumeister 2008 Plasma NPY concentrations during tryptophan and sham depletion in medication-free patients with remitted depression J Affect Disord 110 277 281 10.1016/j.jad.2008.01.014 1:CAS:528:DC%2BD1cXhtVKmtbrE 18281099
19. SJ Davies SD Hood SV Argyropoulos K Morris C Bell HJ Witchel PR Jackson DJ Nutt JP Potokar 2006 Depleting serotonin enhances both cardiovascular and psychological stress reactivity in recovered patients with anxiety disorders J Clin Psychopharmacol 26 414 418 10.1097/01.jcp.0000227704.79740.c0 1:CAS:528:DC%2BD28XntFSmsro%3D 16855462
20. PL Delgado HL Miller RM Salomon J Licinio JH Krystal FA Moreno GR Heninger DS Charney 1999 Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action Biol Psychiatry 46 212 220 10.1016/S0006-3223(99)00014-1 1:CAS:528:DyaK1MXltFOlt7k%3D 10418696
21. Fernstrom JD (1979) Diet-induced changes in plasma amino acid pattern: effects on the brain uptake of large neutral amino acids, and on brain serotonin synthesis. J Neural Transm Suppl (15):55-67
22. CJ Harmer 2008 Serotonin and emotional processing: Does it help explain antidepressant drug action? Neuropharmacology 55 1023 1028 10.1016/j.neuropharm. 2008.06.036 1:CAS:528:DC%2BD1cXht1Knu7vP 18634807
23. JM Hettema 2008 The nosologic relationship between generalized anxiety disorder and major depression Depress Anxiety 25 300 316 10.1002/da.20491 18412057
24. SD Hood SV Argyropoulos J Potokar C Bell J Shufflebotham AS Rich DJ Nutt 2004 A meta-analysis of acute tryptophan depletion studies in anxiety disorders using individual patients' data J Psychopharmacol 18 22
25. SD Hood CJ Bell DJ Nutt 2005 Acute tryptophan depletion. Part I: rationale and methodology Aust N Z J Psychiatry 39 558 564 15996136
26. SD Hood DA Hince H Robinson M Cirillo D Christmas JM Kaye 2006 Serotonin regulation of the human stress response Psychoneuroendocrinology 31 1087 1097 10.1016/j.psyneuen.2006.07.001 1:CAS:528:DC%2BD28XhtVGiu7rI 16962720
27. AK Kulz S Meinzer M Kopasz U Voderholzer 2007 Effects of tryptophan depletion on cognitive functioning, obsessive-compulsive symptoms and mood in obsessive-compulsive disorder: preliminary results Neuropsychobiology 56 127 131 10.1159/000115778 18259085
28. McNair DM, Lorr M, Droppleman LF (1988) Manual for the profile of mood states. Educational and Industrial Testing Service, San Diego
29. JK Melichar A Haida C Rhodes AH Reynolds DJ Nutt AL Malizia 2001 Venlafaxine occupation at the noradrenaline reuptake site: in-vivo determination in healthy volunteers J Psychopharmacol 15 9 12 10.1177/026988110101500102 1:CAS:528:DC%2BD3MXisFymu7g%3D 11277612
30. DS Mennin RG Heimberg DM Fresco MR Ritter 2008 Is generalized anxiety disorder an anxiety or mood disorder? Considering multiple factors as we ponder the fate of GAD Depress Anxiety 25 289 299 10.1002/da.20493 18412056
31. N Praschak-Rieder AA Wilson D Hussey A Carella C Wei N Ginovart MJ Schwarz J Zach S Houle JH Meyer 2005 Effects of tryptophan depletion on the serotonin transporter in healthy humans Biol Psychiatry 58 825 830 10.1016/j.biopsych.2005.04.038 1:CAS:528:DC%2BD2MXht1Ght7jP 16026765
32. JP Redrobe M Bourin MC Colombel GB Baker 1998 Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity Psychopharmacology (Berl) 138 1 8 10.1007/s002130050638 1:CAS:528:DyaK1cXkvVKlurc%3D
33. HG Ruhe NS Mason AH Schene 2007 Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies Mol Psychiatry 12 331 359 10.1038/sj.mp.4001949 1:CAS:528:DC%2BD2sXjsV2isr8%3D 17389902
34. JD Schaechter RJ Wurtman 1990 Serotonin release varies with brain tryptophan levels Brain Res 532 203 210 10.1016/0006-8993(90)91761-5 1:CAS:528:DyaK3MXhsl2huw%3D%3D 1704290
35. K Schruers T Klaassen H Pols T Overbeek NE Deutz E Griez 2000 Effects of tryptophan depletion on carbon dioxide provoked panic in panic disorder patients Psychiatry Res 93 179 187 10.1016/S0165-1781(00)00117-7 1:CAS:528: DC%2BD3cXitlOlu7s%3D 10760376
36. DV Sheehan Y Lecrubier KH Sheehan P Amorim J Janavs E Weiller T Hergueta R Baker GC Dunbar 1998 The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 J Clin Psychiatry 59 Suppl 20 22 33 9881538
37. J Shlik A Aluoja V Vasar E Vasar T Podar J Bradwejn 1997 Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder J Psychiatry Neurosci 22 332 340 1:STN:280:DyaK1c%2FmsVGrsw%3D%3D 9401314
38. KA Smith CG Fairburn PJ Cowen 1997 Relapse of depression after rapid depletion of tryptophan Lancet 349 915 919 10.1016/S0140-6736(96)07044-4 1:STN:280:DyaK2s3kslWiuw%3D%3D 9093253
39. Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA (1983) Manual for the State-Trait Anxiety Inventory. Consulting Psychologists, Palo Alto
40. I Toru J Shlik E Maron V Vasar DJ Nutt 2006 Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopram Psychopharmacology (Berl) 186 107 112 10.1007/s00213-006-0351-1 1:CAS:528:DC%2BD28XjslGisbs%3D
41. HJ van Megen HG Westenberg JA Den Boer B Slaap A Scheepmakers 1997 Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks Psychopharmacology (Berl) 129 357 364 10.1007/s002130050201
42. WA Williams SE Shoaf D Hommer R Rawlings M Linnoila 1999 Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers J Neurochem 72 1641 1647 10.1046/j.1471-4159.1999.721641.x 1:CAS:528:DyaK1MXitFCksbc%3D 10098872
43. World Health Organization (2004) International statistical classification of diseases and related health problems: tenth revision. World Health Organization, Geneva
44. RJ Wurtman JJ Wurtman MM Regan JM McDermott RH Tsay JJ Breu 2003 Effects of normal meals rich in carbohydrates or proteins on plasma tryptophan and tyrosine ratios Am J Clin Nutr 77 128 132 1:CAS:528:DC%2BD3sXhtFyntg%3D%3D 12499331
45. SN Young SE Smith RO Pihl FR Ervin 1985 Tryptophan depletion causes a rapid lowering of mood in normal males Psychopharmacology (Berl) 87 173 177 10.1007/BF00431803 1:CAS:528:DyaL2MXlsFyhtr8%3D